Bilateral superior opthalmic vein thrombosis in a young woman [9]

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 1, 2003, Pages 88-90

  Michaelides, Michel ^a   Aclimandos, Wagih ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ORAL CONTRACEPTIVE AGENT; BLOOD CLOTTING FACTOR 8; FIBRINOLYTIC AGENT;

ADULT; CAROTID CAVERNOUS FISTULA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HUMAN; LETTER; OCULAR BLOOD VESSEL; PRIORITY JOURNAL; SCLERA DISEASE; THYROID FUNCTION TEST; VEIN THROMBOSIS; VISUAL ACUITY; EYE; METABOLISM; RISK FACTOR; THROMBOPHILIA; VASCULARIZATION; VEIN;

ADULT; ASPIRIN; EYE; FACTOR VIII; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; RISK FACTORS; THROMBOPHILIA; VEINS; VENOUS THROMBOSIS;

EID: 0037855893     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00028_9.x     Document Type: Letter

References (7)

1. Berenholz B, Kessler A & Shlomkovitz N (1998): Superior ophthalmic vein thrombosis - complication of ethmoidal rhinosinusitis. Arch Otolaryngol Head Neck Surg 1: 95-97.
2. Brismar G & Brismar J (1977): Aseptic thrombosis of orbital veins and cavernous sinus. Clinical symptomatology. Acta Ophthalmol (Copenh) 55: 9-22.
3. Gorog DA, Rakhit R, Parums D, Laffan M & Davies GJ (1998): Raised factor VIII is associated with coronary thrombotic events. Heart 80: 415-417.
4. Jaais F & Habib ZA (1994): Unilateral superior ophthalmic vein thrombosis in a user of oral contraceptives. Med J Malaysia 49: 416-418.
5. Luxenberg MN (1991): Colour doppler imaging of superior ophthalmic vein thrombosis. Arch Ophthalmol 109: 582-583.
6. Schuknecht B, Simmen D, Yüksel C & Valavanis A (1998): Tributary venosinus occlusion and septic cavernous sinus thrombosis: CT and MR findings. Am J Neuroradiol 19: 617-626.
7. Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M & Heinemann L (2000): Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod 15: 817-821.